EQSNews: BRAIN Biotech AG
/ Key words: Annual Report/Annual Results
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy
17.01.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Annual Report 2022/23: BRAIN Biotech AG successfully ex... Lire le communiqué |
|
|
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Miscellaneous
Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy
20.11.2023 / 09:44 CET/CEST
The issuer is solely responsible for the content of this announcement.
Akribion Genomics receives the Hessia... Lire le communiqué |
|
|
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Miscellaneous
BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
28.09.2023 / 10:30 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Patent
BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease Gdase E®
14.09.2023 / 10:30 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Miscellaneous
BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
12.09.2023 / 15:45 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
|
EQSNews: BRAIN Biotech AG
/ Key words: 9 Month figures/Quarterly / Interim Statement
BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
30.08.2023 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Miscellaneous
BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
28.06.2023 / 13:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotec... Lire le communiqué |
|
|
|
|